Vitamin D Supplementation in Pediatrics. Oral or Parenteral! D2 or D3

Vitamin D Supplementation in Vitamin D Deficient/Insufficient Children Oral or Parenteral! D2 or D3, A Randomized Controlled Trial.

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06176157

Enrollment

120

Registered

2023-12-19

Start date

2023-12-31

Completion date

2024-04-30

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Deficiency

Keywords

Vitamin D, ergochalciferol, cholecalciferol, oral, parenteral

Brief summary

A study will be performed on Vitamin D deficient/ insufficient Egyptian children to compare the efficacy of oral and parenteral forms of Ergocalciferol and cholecalciferol in raising serum 25(OH) D levels in these subjects

Interventions

DIETARY_SUPPLEMENTvitamin D2, vitamin D3

comparing parentral D2, D3, to oral D2, D3

Study design

Allocation

RANDOMIZED

Intervention model

SEQUENTIAL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

5 Years to 10 Years

Healthy volunteers

Yes

Inclusion criteria

* laboratory evidence of vitamin D deficiency or insufficiency without clinical signs of rickets

Exclusion criteria

* vitamin D or calcium supplementation within the last 6 months before inclusion, patients with diabetes mellitus, chronic liver disease and kidney disease, congenital or rheumatic heart disease, malabsorption syndromes, thyroid disease, juvenile rheumatic diseases, or other bone disorders.

Design outcomes

Primary

Measure	Time frame
serum 25(OH) D level after 1,2,3 months of supplementation	3 months

Contacts

Primary ContactMarwa M Nawar, Lecturer

marwa_magdy@med.asu.edu.eg+201005368647

Backup ContactHeba H ELsedfy, professor

hebased@yahoo.com+201005189166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026